{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T05:02:26Z","timestamp":1785301346806,"version":"3.55.0"},"reference-count":13,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute myelopathy in patients with small cell lung cancer (SCLC) is often attributed to metastatic spinal cord involvement. However, non-compressive inflammatory conditions, particularly aquaporin-4 immunoglobulin G (AQP4-IgG)-positive neuromyelitis optica spectrum disorder (NMOSD), can produce similar clinical and radiologic features, creating substantial diagnostic uncertainty.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A male aged 65 years with extensive-stage SCLC presented with acute urinary retention followed by rapidly progressive paraplegia. Spinal magnetic resonance imaging (MRI) revealed longitudinally extensive intramedullary T2-hyperintense lesions affecting the cervical and thoracic spinal cord, with patchy contrast enhancement and no evidence of vertebral destruction, epidural mass, or spinal cord compression. Cerebrospinal fluid (CSF) examination demonstrated inflammatory abnormalities without malignant cells, and infectious causes were excluded. Serum and CSF testing were strongly positive for AQP4-IgG, establishing a diagnosis of AQP4-IgG-positive NMOSD. The patient received high-dose intravenous methylprednisolone followed by adjunctive intravenous immunoglobulin (IVIG). Plasma exchange was not performed because of advanced malignancy and concerns regarding procedural risks. Satralizumab was initiated during corticosteroid tapering for maintenance immunotherapy. Neurological function subsequently stabilized, and partial recovery of independence in activities of daily living was achieved.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This case highlights that AQP4-IgG-positive myelitis can occur in patients with SCLC. In patients presenting with non-compressive longitudinally extensive transverse myelitis (LETM), particularly when imaging shows no evidence of compression and CSF cytology is negative for malignant cells, prompt AQP4-IgG testing is critical to prevent misdiagnosis and enable early initiation of appropriate immunotherapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1867559","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:34:23Z","timestamp":1785299663000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["AQP4-IgG-positive myelitis occurring in a patient with small cell lung cancer: a case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Meijian","family":"Yang","sequence":"first","affiliation":[{"name":"Oncology Department II, Hebei General Hospital","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongjie","family":"Du","sequence":"additional","affiliation":[{"name":"Vascular Surgery Department, Hebei General Hospital","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoci","family":"Cao","sequence":"additional","affiliation":[{"name":"Oncology Department II, Hebei General Hospital","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[{"name":"Oncology Department II, Hebei General Hospital","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[{"name":"Oncology Department II, Hebei General Hospital","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00115-007-2262-8","article-title":"The history of neuromyelitis optica","volume":"10","author":"Jarius","year":"2013","journal-title":"J Neuroinflamm"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jocn.2017.10.030","article-title":"Paraneoplastic neuromyelitis optica spectrum disorder: a case report and review of the literature","volume":"48","author":"Annus","year":"2018","journal-title":"J Clin Neurosci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/nyas.12794","article-title":"Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin\u20104 channelopathies: a decade later","volume":"1366","author":"Pittock","year":"2016","journal-title":"Ann N Y Acad Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13123590","article-title":"Comprehensive insights into metastasis-associated spinal cord compression: pathophysiology, diagnosis, treatment, and prognosis: a state-of-the-art systematic review","volume":"13","author":"Vavourakis","year":"2024","journal-title":"J Clin Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-014-0483-3","article-title":"Short myelitis lesions in aquaporin-4-IgG\u2013positive neuromyelitis optica spectrum disorders","volume":"72","author":"Flanagan","year":"2015","journal-title":"JAMA Neurol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-811161-1.00015-3","article-title":"Epidural and intramedullary spinal metastasis: clinical features and role of fractionated radiotherapy","volume":"149","author":"Rades","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2282","article-title":"AQP4\u2010IgG positive paraneoplastic NMOSD: a case report and review","volume":"11","author":"Ding","year":"2021","journal-title":"Brain Behav"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.1071519","article-title":"Neuromyelitis optica spectrum disorders associated with AQP4-positive-cancer\u2014a case series","volume":"13","author":"Duan","year":"2022","journal-title":"Front Neurol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2023.120825","article-title":"Aquaporin-4-IgG positive neuromyelitis optica spectrum disorder in a paraneoplastic context","volume":"454","author":"Hyun","year":"2023","journal-title":"J Neurol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2018.01.003","article-title":"A case of paraneoplastic neuromyelitis optica associated with small cell lung carcinoma","volume":"316","author":"Deuel","year":"2018","journal-title":"J Neuroimmunology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2018.14.2.246","article-title":"Paraneoplastic neuromyelitis optica associated with lung adenocarcinoma in a young woman","volume":"14","author":"Baik","year":"2018","journal-title":"J Clin Neurol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1901747","article-title":"Trial of satralizumab in neuromyelitis optica spectrum disorder","volume":"381","author":"Yamamura","year":"2019","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1867559\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:34:33Z","timestamp":1785299673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1867559\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":13,"alternative-id":["10.3389\/fonc.2026.1867559"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1867559","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"article-number":"1867559"}}